NPA, USP Provide GMP Support To Chinese Dietary Supplement Suppliers
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - All dietary supplements marketed in the U.S. will need to adhere to new Good Manufacturing Practices by the end of June 2010, National Products Association VP - Scientific and Regulatory Affairs Daniel Fabricant told a recent seminar in Shanghai
You may also be interested in...
China’s State FDA Enforces New Rules For Traditional Chinese Medicine Registration
SHANGHAI - China's State FDA introduced new supplementary requirements for registering traditional Chinese medicine Jan. 8, to separate the process from western drug registration
Import Safety Agreement Further Entwines FDA/China Regulatory Process
Chinese manufacturers of certain drugs or active pharmaceutical ingredients selected by FDA will have to meet new registration standards as part of a memorandum of understanding signed Dec. 11 in Beijing by HHS, FDA and China's State Food and Drug Administration
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).